Clinical trial interoperability has evolved beyond a technology integration initiative. It has become an operational priority that influences study execution, data quality, regulatory readiness, and decision-making across the clinical development lifecycle. As organizations seek to modernize their clinical platforms, engineering delivery models are also evolving to support closer alignment between technology implementation and business outcomes. Forward Deployed Engineering is emerging as one such delivery model.

Did you know that the ACRP Board of Trustees includes a public member whose role is to champion the public or consumer interest in the drug and device research and development enterprise? They are chosen to bring new ideas and goals to the table, contribute an unbiased perspective, encourage consumer-oriented positions, and offer additional public accountability and responsiveness. We asked Toni Willis, MD, FAAPMR, the current ACRP Public Member, to share some background on her career and how she came to serve in this volunteer role.